Clinical trial

Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer

NCT01731912

Study summary

ClinicalTrials.gov

Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Degarelix Normalized identity: degarelix View linked drug · Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention External Beam Radiation Therapy Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Laboratory Biomarker Analysis Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-05-01

PhaseNA

Conditions

Prostate Adenocarcinomaverified · MONDO: prostate adenocarcinoma

Stage IIA Prostate Cancerunresolved

Stage IIB Prostate Cancerunresolved

Stage III Prostate Cancerunresolved

Stage IV Prostate Cancerunresolved

Interventions

DegarelixDRUG · verified · RxNorm: degarelix

External Beam Radiation TherapyRADIATION

Laboratory Biomarker AnalysisOTHER

Sponsors & collaborators

University of Washingtonlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01731912 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.